Funding for Faculty

Additional Details

RFP Snapshot: The Siteman Biostatistics and Qualitative Research Shared Resource provides advice and support to PIs in preparation of grant applications.

Max Amount and Period: N/A

Eligibility: Must be Siteman Cancer Center members.

Due Date: Rolling

Additional Details

RFP Snapshot: The WUSTL CDC has various match funding programs as follows:

• CDD Match Grant15
• CDD Match Grant25

Max Amount and Period: Varies

Eligibility: Varies

Due Date: Rolling

Additional Details

RFP Snapshot: The purpose of these Precision Health Innovation awards is to advance initial discovery pilots for Precision Health ICTS investigators. Proposals are not for developed projects but are to fund developmental or early stage work, including pilot data collection and analysis, in preparation for submission of future external funding.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must be full time faculty at WUSTL or an ICTS partner institution and must be a member of the ICTS.

Due Date: Rolling

Additional Details

RFP Snapshot: The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores (pdf) for research advancing medical knowledge that can improve human health. The Siteman Cancer Center will co-sponsor cancer-focuses proposals.

Max Amount and Period: Varies

Eligibility: Applicant must be a registered member of the ICTS and hold a faculty level appointment at WUSTL or an ICTS partner institution.

Due Date: Rolling

Additional Details

RFP Snapshot: Team Science Awards are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Evidence of prior collaboration among team members is encouraged, but not required.

Max Amount and Period: $900,000 over 3 years

Eligibility: Team must be multidisciplinary, and consist of two or more established Principal Investigators, one of whom is designated the Administrative PI, a Young Investigator with complementary expertise, and a Mentor for the Young Investigator. All Young Investigators on Team Science Award applications must complete the Applicant Eligibility Checklist and upload it as an attachment with the LOI.

Due Date: Letter of Intent Due: September 20, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may also each out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be physicians (MD, DO, or equivalent), in the last two years of their final oncology subspecialty training AND within 10 years of obtaining their medical degree. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period. Applicants must have a mentor working in the proposed research field. Applicants must be ASCO members. Nonmembers must submit a membership application with the grant. Lastly, applicants must be able to commit at least 60% of full-time effort to total research.

Due Date: September 21, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. For purposes of this Request for Proposals (RFP), “global health” is described as an “area for study, research, and practice that places a priority on improving health and achieving health equity for all people worldwide.” An important goal of the GO YIA program is to support quality global oncology research by investigators based in low-resource settings. Therefore, applicants from LMICs are highly encouraged to apply.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must have a doctoral degree (MD, PhD, MD/PhD, DO, or equivalent), in the last year of their training or within the first 2 years of employment at the time of submission and must be within 10 years of terminal degree. Applicants must be ASCO members. Nonmembers must submit a membership application with the grant. Lastly, applicants must be able to commit at least 60% of full-time effort to total research.

Due Date: Letter of Intent Due: September 21, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Researchers under this award identify as either a “Young Investigator” or as an “Independent Investigator.” The application must address at least one of the priority areas listed in the RFA related to cancer in children, adolescents, and/or young adults up to age 24.

Max Amount and Period: $100,000 over 2 years

Eligibility: All academic ranks from Instructor to Professor with MD, DO, PharmD, and/or PhD degrees may apply. PIs need not be US citizens.

Due Date: Letter of Intent Due: September 22, 2023 at 2:30PM CST

Application Assistance: Washington University faculty may also each out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Consortium grants are for three or more institutions collaborating on a grant-supported research project. The application must address at least one of the priority areas listed in the RFA related to cancer in children, adolescents, and/or young adults up to age 24.

Max Amount and Period: $200,000 over 2 years

Eligibility: All academic ranks from Instructor to Professor with MD, DO, PharmD, and/or PhD degrees may apply. PIs need not be US citizens. Consortiums are three or more institutions collaborating on a research project.

Due Date: Letter of Intent Due: September 22, 2023 at 2:30PM CST

Application Assistance: Washington University faculty may also each out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The PhRMA Foundation recognizes the need to enhance diversity in clinical trials, and the use of digital health tools also has the potential to support more equitable participation in medical research. Through this new program, the Foundation will invest in research on the use of DHTs in underrepresented populations in clinical trials to advance regulatory decision-making. Based on letters of intent, the PhRMA Foundation scientific advisory committee will select up to eight candidates to submit a full application, including a detailed research proposal and budget. Each of these candidates will receive a planning grant of $25,000 and have three months to submit their full application. From those submitted applications, up to two candidates will receive a $500,000 award.

Max Amount and Period: $500,000 over 3 years (

Eligibility: U.S. citizens and non-U.S. citizens are eligible to apply for this award. Funding is conditional upon the continued employment of the lead PI with the university.

Due Date: Letter of Intent Due: September 29, 2023 at 11AM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at [email protected] with any questions and for assistance with the proposal, including gathering pertinent catchment statistics regarding disparities.

Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is intended to support innovative clinical research proposals with a focus on better treatment strategies in childhood medulloblastoma research. Research projects should be clinical in nature, with outcomes that will ultimately impact treatment outcomes in childhood medulloblastoma patients. Pre-clinical projects based on animal models including animal, or human organoid cultures are not appropriate for this funding opportunity. Project proposals should have measurable outcomes during the one-year grant period.

Max Amount and Period: $100,000 for 1 year

Eligibility: The lead PI must hold a MD, PhD, MD/PhD, or equivalent and must be able to commit at least 60% of their full-time effort to research (total research) during the award period. The team must include one new investigator (no substantial, independent funding from NIH) who is planning a career in oncology with a focus on medulloblastoma. The team also must involve a patient advocate’s participation in the project’s development. Applicants need not be US citizens or permanent residents.

EXTENDED Due Date: Letter of Intent Due: September 29, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This opportunity is seeking research proposals from any relevant discipline that will advance basic, translational, or clinical science in Adolescent and Young Adult (AYA) Oncology (defined as cancer patients or survivors diagnosed at 15 to 39 years of age).

Max Amount and Period: $50,000 over 1 to 2 years

Eligibility: Young investigators within the first 5 years of completing fellowship or equivalent training that are members of any NCTN cooperative group may submit applications. The applicant must be a US resident and must have a faculty position at the start of the award. Candidates from pediatric oncology, medical oncology, nursing, psychology, neuropsychology, radiation oncology, and other fields relevant to AYA cancer-related research are encouraged to apply.

Due Date: September 30, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports junior faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. Specifically, for this RFA in partnership with ASTRO, the applicant MUST be in the radiation oncology field.

Max Amount and Period: $405,000 to $675,000 over 3 to 5 years

Eligibility: Applicants must have a clinician license and play a role in clinical care. They must have either a clinical doctoral degree (MD, DO, DDS, DNP, DSW, PharmD, etc.) or they must be a medical physicist (MS or PhD). Applicants must not have had an NIH K-type or other mentored award and must not have had an R-level or equivalent grant as PI.

Due Date: October 15, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: We accept proposals that could lead to the prevention of any inherited cancer. We will consider research projects that can contribute to broader understanding in various areas related to premalignant stages, transformation, early detection, and the development of assays/models and preventive therapies. Priority will be given to proposals focused on the following categories: the basic biology of cancer initiation, early detection, and/or early intervention.

Max Amount and Period: $450,000 over 3 years

Eligibility: The CPI welcomes research ideas from all individuals irrespective of their background or professional roles. Applicants need not be a principal investigator or a clinician to apply. If a prospective applicant has a new idea for a project rooted in scientific rationale and the potential to revolutionize cancer prevention, they are encouraged to apply.

Due Date: Letter of Intent Due: October 15, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The intent of this program is to support the development and diversity of talent working in pancreatic cancer research. Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences workforce.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applicants must be members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences workforce. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent). At the start of the grant term (July 1, 2024), applicants must have independent laboratory space and hold a faculty appointment at the rank of Instructor, Assistant Professor, Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, or Visiting Professor. There are no citizenship requirements. Applicants must be AACR members. Non-members can apply for membership here.

Due Date: October 16, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The intent of this program is to support the development and diversity of talent working in pancreatic cancer research. This Award represents a joint effort to support the career advancement of a female scientist engaged in pancreatic cancer research.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applicants must be female scientists with a doctoral degree (PhD, MD, MD/PhD, or equivalent). At the start of the grant term (July 1, 2024), applicants must have independent laboratory space and hold a faculty appointment at the rank of Instructor, Assistant Professor, Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, or Visiting Professor. There are no citizenship requirements. Applicants must be AACR members. Non-members can apply for membership here.

Due Date: October 16, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This award represents a joint effort to support innovative research to advance efforts towards the early detection and interception of pancreatic cancer.

Max Amount and Period: $300,000 over 3 years

Eligibility: Applications from investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to pancreatic cancer research are especially encouraged. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent). Postdoctoral or clinical research fellows who are working under the auspices of a scientific mentor are NOT eligible to apply. There are no citizenship requirements. Applicants must be AACR members. Non-members can apply for membership here.

Due Date: October 16, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports junior faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.

Max Amount and Period: $405,000 to $675,000 over 3-5 years

Eligibility: Applicants must have a clinician license and play a role in clinical care. They must be within the first 6 years of their first full-time faculty appointment and have had less than 3 years of mentored post-doctoral research experience. Applicants must not have had an NIH K-type or other mentored award and must not have had an R-level or equivalent grant as PI.

Due Date: October 16, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Discovery Boost Grants (DBG) support high-risk, high-reward exploratory cancer research across the research continuum. Investigators may focus on developing research methodologies, establishing feasibility, or leading pilot tests.

Max Amount and Period: $250,000 over 2 years

Eligibility: Applicants must have a MD, PhD, DVM, or equivalent and have a full-time faculty position. Independent investigators at any career stage are eligible to apply.

Due Date: October 16, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This mechanism is intended to fund pilot, first-in-field, innovative strategies that increase quality cancer screening, clinical trials—and cancer care closer to home. AHEAD Awards will fund exploratory, novel research studies that seek to improve access to quality cancer screening and/or cancer care by bringing technologies to individuals rather than requiring travel to healthcare facilities.

Max Amount and Period: $250,000 over 2 years

Eligibility: The applicant must have a doctoral degree and have an independent faculty appointment.

Due Date: October 16, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Program Webinar: Contact program contact Kimberly Clark at [email protected] for a recording of last year’s webinar.

Additional Details

RFP Snapshot: Research Scholar Grants (RSG) provide support for independent, self-directed researchers and clinician scientists, who are investigators licensed to provide patient care and trained to conduct research.

Max Amount and Period: Focus A: $660,000 over 4 years; Focus B: $1M over 5 years (for large, multi-level studies on Cancer Health Equity)

Eligibility: Focus A: Any ACS Priority Research Area:

Applicants must be within the first 10 years of their first independent, full-time faculty appointment and be the PI on NO MORE THAN ONE (1) R01 or R01-equivalent grant at the time of application.

Focus B: Cancer Health Equity OR Health Policy/Health Services Research:

Applicants may be at any stage of their career and have any amount of funding.

Due Date: October 16, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at [email protected] with any questions and for assistance with the proposal, including gathering pertinent catchment statistics regarding disparities.

Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects. Stage 1 requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients. Stage 2 supports testing in cancer patients.

Max Amount and Period: Stage 1: $200,000 over 2 years; Stage 2: $500,000 over 1.5 years (18 months)

Eligibility:

Stage 1:

Applicants must have held or currently hold one of the following ACS grants (or previous versions of such awards) for a minimum of one year: Research Scholar Grant (RSG), Clinician Scientist Development Grant (CSDG), Mentored Research Scholar Grant (MRSG), Cancer Control Career Development Award (CCCDA), Pilot and Exploratory Projects in Palliative Care (PEP) Award, or ACS Postdoctoral Fellowships (previous fellows only).

Stage 2:

Applicants must have held or currently hold a Stage 1 Mission Boost Grant (MBG) for a minimum of 18 months and have completed the specific stage 1 milestones.

Due Date: October 16, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Innovation Grant is designed to provide critical and significant seed funding for researchers with a novel approach to pediatric oncology scientific investigation. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.

Max Amount and Period: $250,000 over 2 years

Eligibility: At the time of application, applicants must have a MD, PhD, or MD/PhD and must have a faculty appointment. Applicants must have a track record of publication and funding productivity that demonstrates the project can be accomplished. Applicants must propose a new research direction, not a continuation of ongoing funded research. Applicants need not be US citizens.

Due Date: Letter of Intent Due: October 16, 2023 at 7PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This mechanism will support translational, clinical, or epidemiological research that has direct applicability and relevance to bladder cancer. Projects must demonstrate the likelihood of translating new concepts into clinical practice.

Max Amount and Period: $250,000 over 3 years

Eligibility: Applicants must be early-career investigators (within the initial 7 years of their first full-time faculty appointment with the title of Instructor, Research Assistant Professor, or Assistant Professor, or equivalent, who have not yet received a major independent research award (NIH R01 or equivalent).

Due Date: October 18, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Max Amount and Period: $200,000 over 3 years

Eligibility: The applicant must be a physician (MD, DO, or international equivalent) and must be in the first to fourth year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. The application must be submitted before the applicant has had four full years as faculty. Must be an ASCO member or have submitted a membership application with the grant application. They must be able to commit at least 50% of full-time effort in research. The applicant may not concurrently hold other career development awards. See RFA for full eligibility guidelines.

Due Date: October 19, 2023 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of this jointly-supported award is to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to translational cancer research.

Max Amount and Period: $50,000 for 1 year

Eligibility: At the start of the grant term (July 1, 2024), applicants must be in the last two years of their final subspecialty training and within ten years of obtaining their medical degree. They must have a valid, active medical license in the country where the research will be conducted and have a mentor in the proposed research field from the sponsoring institution. The applicant must be able to commit at least 60% of full-time effort to their research (total research) and be planning an investigative career in clinical oncology. There are no citizenship requirements. Applicants must be AACR members. Non-members can apply for membership here.

Due Date: October 31, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This new Susan G. Komen grant is intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically marginalized in research. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever.

Max Amount and Period: $200,000 over 2 years

Eligibility: The applicant will serve as the Lead Mentor for the Trainee supported by this grant supplement and must hold a tenure-track faculty position with adequate space for an additional trainee. The PI must have a currently funded breast cancer research project that has undergone rigorous peer review by Susan G. Komen, the Department of Defense, the NIH, or the NSF and the project must have at least one year of grant funds remaining at the time of award (on or around April 15, 2024). The applicant is not required to be a U.S. citizen or permanent resident.

Trainees supported through this supplement are from groups shown to be historically minoritized and marginalized in biomedical research from National Science Foundation data. This includes individuals who identify as Black or African American, Latino or Hispanic, American Indian or Alaska Native, Native Hawaiian and other Pacific Islanders; individuals with disabilities; and individuals from disadvantaged backgrounds according to the criteria used by the NIH (https://diversity.nih.gov/about-us/population-underrepresented). Trainees must be able to devote at least 75% of full-time effort to breast cancer research and activities. No US citizenship or permanent resident requirements.

Due Date: November 1, 2023 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The program is seeking outstanding midcareer health professionals, behavioral and social scientists, and others with an interest in health and the drivers of health who are skilled and committed; with expertise in health and health equity; and can offer an informed perspective on important and complex challenges facing policymakers. Fellows actively participate in the policy process in congressional or executive branch offices of their choosing and leverage this leadership experience to promote policies, practices, and systems changes that advance health and health equity.

Max Amount and Period: $175,000 for 1 year

Eligibility: Applicants must hold a masters or doctoral degree and have deep experience and subject matter expertise in a health-related discipline. Individual applicants must be US citizens or permanent residents at the time of application. Individual candidates for receipt of award funds cannot be related by blood or marriage to any Officer or Trustee of the Robert Wood Johnson Foundation, or be a descendant of its founder, Robert Wood Johnson.

Due Date: November 1, 2023 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across genomic research areas and will incorporate a plan for enhancing diverse perspectives.

Max Amount and Period: $2.5M over 5 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: November 8, 2023 at 5PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must hold a faculty appointment as a tenure-track Assistant Professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. The grant will be awarded to a scientist who describes an extraordinarily novel, yet practical research plan that is creative and technically sophisticated.

Due Date: Letter of Intent Due: November 15, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Osteosarcoma Institute grant programs provide both immediate hope to patients through clinical trials and long-term hope through earlier-stage translation of scientific ideas that have the potential to result in a new treatment. The mechanisms include funding for (1) Phase I/II or Phase II clinical trials, (2) Correlative Science, (3) Preclinical/Translational Research Projects, and (4) the High-Risk/High-Impact projects.

• Phase I/II or Phase II Clinical Trials – $800,000 over 3 years
  Primary objective should be to improve event free survival at 4 months, beyond historical rates known to be in the range of 12%. The proposed trial may be carried out in a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure. OSI will not prioritize the launch of new infrastructures to conduct clinical trials.
• Correlative Science – $500,000 over 3 years
  Correlative studies should seek to generate data in support of clinical trials seeking to improve event free survival of recurrent and metastatic osteosarcoma patients. Our highest priority for correlative science proposals is those that will create the opportunity, should the associated clinical trial fail, to understand the reasons for that failure and allow for productive iteration of the approach.
• Preclinical / Translational Research – $500,000 over 2 years
  A translational imperative for the OSI is to cultivate and support a research agenda that will identify biological dependencies in the disease that can be targeted in patients. This research agenda will ideally include the use of novel laboratory approaches and bioinformatic tools applied to osteosarcoma cells, a diversity of in vivo models across species and human patient samples.
• High-Risk/High-Impact Research – $125,000 over 1 year
  This new pilot grant program is for bold new ideas that may fall within any part of a drug development path, and that seek to deliver curative outcomes to patients with osteosarcoma. These proposals will be most valued based on their innovation and the likelihood that the approach will target a true dependency in osteosarcoma.

Max Amount and Period: See mechanism specifics above

Eligibility: Applicants must have an MD, PhD, MD/PhD, or equivalent and have a faculty appointment. Applicants need not be US citizens. Applicants must have a track record of publication and funding that demonstrates the accomplishment ability of the project. Applicants must propose a new research direction, not a continuation of ongoing funded research.

Due Date: Letter of Intent Due: November 15, 2023 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.